No Data
No Data
Lake Street Maintains P3 Health Partners(PIII.US) With Buy Rating, Cuts Target Price to $20
Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $20
P3 Health Partners Analyst Ratings
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
P3 Health Partners To Carry Out 1-for-50 Reverse Stock Split On April 14th, 2025
April 10th (Eastern Time) - $P3 Health Partners(PIII.US)$ is about to implement a 1-for-50 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from April 14th, 2025
Medicare Advantage Rates Expected To Climb Over 5% In 2026, Easing Pressure On Managed Care